Drawing for GNTPHARMA

USPTO serial 79315635

GNTPHARMA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
WINTER, MELISSA S
Law office
TMO LAW OFFICE 122 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with GNTPHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for animals; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations and substances with anti-inflammatory properties; pharmaceutical preparations for veterinary use; pharmacological preparations for skin care; pharmaceutical preparations for the treatment of cardiovascular disease; chemico-pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammatory diseases; medicated hair care preparations; medicated hair care preparations; medicines for human purposes; pharmaceutical preparations acting on the central nervous system; ethical medicinal preparations; pharmaceutical preparations for the treatment; pain relief medication; burn relief medications; preparations for the treatment of burnsACTIVE—
042Drug discovery services; conducting clinical trials in the field of cardiovascular disease; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; clinical testing of medicines; scientific research in the field of pharmacy; medicine research; providing information on the testing/inspection/research of medical products; medical and pharmacological research services; clinical trials; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; cosmetics research; cosmetics development services; technological services and research relating thereto; remote monitoring services for medical diagnostic devices [remote monitoring of medical diagnostic systems]; research and development of medical equipmentACTIVE—
044Preparation and dispensing of medications; medical and health care clinic services; rental of equipment for medical purposes; medical diagnostic services; medical analysis relating to clinical data; advisory services relating to the treatment of degenerative diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 30, 2024FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 5, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 5, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 8, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 5, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 5, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 5, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 4, 2023DOCKASSIGNED TO EXAMINER—
Dec 21, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 21, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 24, 2022RFNTREFUSAL PROCESSED BY IB—
May 5, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 5, 2022RFRRREFUSAL PROCESSED BY MPU—
Apr 30, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 29, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2022DOCKASSIGNED TO EXAMINER—
Jul 24, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 20, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 15, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance